Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

Ling Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0087-3034; OpenAlex author ID A5100435324. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers

Papers 3

  1. A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. Last author DOI 10.3389/fonc.2022.1015042↗
  2. AK4P1 is a cancer-promoting pseudogene in pancreatic adenocarcinoma cells whose transcripts can be transmitted by exosomes. Co-author DOI 10.3892/ol.2022.13283↗
  3. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Co-author DOI 10.1158/1078-0432.ccr-13-0621↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhi‐Nan Chen · 2 shared papers, 2013–2022 · strength 0.18
  2. Mingshui Xie · 1 shared paper, 2022 · strength 0.17
  3. Xue Liang · 1 shared paper, 2022 · strength 0.15
  4. Xin‐Yu Fan · 1 shared paper, 2022 · strength 0.15
  5. Hao Wang · 1 shared paper, 2022 · strength 0.15
  6. Theodore Steven Lawrence · 1 shared paper, 2013 · strength 0.03
  7. Liang Xu · 1 shared paper, 2013 · strength 0.03
  8. Jiayuh Lin · 1 shared paper, 2013 · strength 0.03
  9. Xiaoqing Wu · 1 shared paper, 2013 · strength 0.03
  10. David M. Karnak · 1 shared paper, 2013 · strength 0.03
  11. Diane M. Simeone · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.